The query asks for a meta-analysis and methodological critique of C. K. Fairley's systematic review work, but none of the eight supplied evidence records involve Fairley or systematic review methodology. They cover distinct NSCLC topics: LDOC1-clathrin adaptor interactions regulating EGFR internalization in a 200-patient cohort , EGFR copy-number screening failure in 96 lung adenocarcinomas , and EGFR-TKI resistance reviews .
What is missing: the target review by C. K. Fairley, its full text, PRISMA/AMSTAR-2/ROBIS appraisal criteria, or any extracted claims from it. Without these, no valid critique or pooled analysis is possible. Please supply the Fairley review or its full text to proceed.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.